ICAM1 and endothelial dysfunction: Furthermore, ICAM-1 and VCAM-1 are characteristic molecules of endothelial dysfunction (Zonneveld et al. 2014), which also illustrates the superior effects of BMMSCs for reducing hepatic sinusoidal endothelial and vascular endothelial injury.